Amyotrophic lateral sclerosis as a complex genetic disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1762, Issue 11-12, 2006, Pages 973-985

  Simpson, Claire L ^a   Al Chalabi, Ammar ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Association study; Complex disease; Complex genetic; Gene; Genetic; Sporadic

Indexed keywords

ANGIOGENIN; APOLIPOPROTEIN E; CILIARY NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; DYNACTIN; DYNEIN ADENOSINE TRIPHOSPHATASE; PERIPHERIN; SURVIVAL MOTOR NEURON PROTEIN; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL FEATURE; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; NEUROFILAMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STATISTICS;

AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERMEDIATE FILAMENTS; MICE; MICE, TRANSGENIC; MUTATION; NEURONS; SUPEROXIDE DISMUTASE;

EID: 33751120678     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.08.001     Document Type: Review

References (156)

1. Kurland L.T., and Mulder D.W. Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. I Neurology 5 (1955) 182-196
2. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
3. Siddique T., Figlewicz D.A., Pericak-Vance M.A., Haines J.L., Rouleau G., Jeffers A.J., Sapp P., Hung W.Y., Bebout J., McKenna-Yasek D., et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N. Engl. J. Med. 324 (1991) 1381-1384
4. Andersen P.M., Nilsson P., Ala-Hurula V., Keranen M.L., Tarvainen I., Haltia T., Nilsson L., Binzer M., Forsgren L., and Marklund S.L. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat. Genet. 10 (1995) 61-66
5. Jackson M., Al-Chalabi A., Enayat Z.E., Chioza B., Leigh P.N., and Morrison K.E. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann. Neurol. 42 (1997) 803-807
6. Jones C.T., Shaw P.J., Chari G., and Brock D.J. Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol. Cell. Probes 8 (1994) 329-330
7. Jones C.T., Swingler R.J., and Brock D.J. Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum. Mol. Genet. 3 (1994) 649-650
8. C.A.S. Johnston, B.R., M.R. Turner, R. Gray, H.-M. Blunt, D. Butt, M.A. Ampong, C.E. Shaw, P.N. Leigh, A. Al-Chalabi, Amyotrophic Lateral Sclerosis in an Urban Setting: a population based study of inner city London. J. Neurol. (in press).
9. Graham A.J., Macdonald A.M., and Hawkes C.H. British motor neuron disease twin study. J. Neurol., Neurosurg. Psychiatry 62 (1997) 562-569
10. Falconer D.S. Introduction to Quantitative Genetics. 2nd ed. (1981), Longman, London
11. de Knijff P., van den Maagdenberg A.M., Frants R.R., and Havekes L.M. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum. Mutat. 4 (1994) 178-194
12. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
13. Chapman J., Vinokurov S., Achiron A., Karussis D.M., Mitosek-Szewczyk K., Birnbaum M., Michaelson D.M., and Korczyn A.D. APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 56 (2001) 312-316
14. Crawford F.C., Vanderploeg R.D., Freeman M.J., Singh S., Waisman M., Michaels L., Abdullah L., Warden D., Lipsky R., Salazar A., and Mullan M.J. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 58 (2002) 1115-1118
15. Friedman G., Froom P., Sazbon L., Grinblatt I., Shochina M., Tsenter J., Babaey S., Yehuda B., and Groswasser Z. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 52 (1999) 244-248
16. Lendon C.L., Harris J.M., Pritchard A.L., Nicoll J.A., Teasdale G.M., and Murray G. Genetic variation of the APOE promoter and outcome after head injury. Neurology 61 (2003) 683-685
17. Teasdale G.M., Murray G.D., and Nicoll J.A. The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. Brain 128 (2005) 2556-2561
18. Teasdale G.M., Nicoll J.A., Murray G., and Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350 (1997) 1069-1071
19. Mui S., Rebeck G.W., McKenna-Yasek D., Hyman B.T., and Brown Jr. R.H. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 460-463
20. Siddique T., Pericak-Vance M.A., Caliendo J., Hong S.T., Hung W.Y., Kaplan J., McKenna-Yasek D., Rimmler J.B., Sapp P., Saunders A.M., Scott W.K., Siddique N., Haines J.L., and Brown R.H. Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis. Neurogenetics 1 (1998) 213-216
21. Bachus R., Bader S., Gessner R., and Ludolph A.C. Lack of association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Ann. Neurol. 41 (1997) 417
22. Smith R.G., Haverkamp L.J., Case S., Appel V., and Appel S.H. Apolipoprotein E epsilon 4 in bulbar-onset motor neuron disease. Lancet 348 (1996) 334-335
23. Al-Chalabi A., Enayat Z.E., Bakker M.C., Sham P.C., Ball D.M., Shaw C.E., Lloyd C.M., Powell J.F., and Leigh P.N. Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet 347 (1996) 159-160
24. Moulard B., Sefiani A., Laamri A., Malafosse A., and Camu W. Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis. J. Neurol. Sci. 139 (1996) 34-37 (Suppl.)
25. Drory V.E., Birnbaum M., Korczyn A.D., and Chapman J. Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. J. Neurol. Sci. 190 (2001) 17-20
26. Falk C.a.R., and P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51 (1987) 227-233
27. Spielman R.a.M., R.E., and Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52 (1993) 506-516
28. Li Y.J., Pericak-Vance M.A., Haines J.L., Siddique N., McKenna-Yasek D., Hung W.Y., Sapp P., Allen C.I., Chen W., Hosler B., Saunders A.M., Dellefave L.M., Brown Jr. R.H., and Siddique T. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics 5 (2004) 209-213
29. Andersen P.M., Nilsson P., Keranen M.L., Forsgren L., Hagglund J., Karlsborg M., Ronnevi L.O., Gredal O., and Marklund S.L. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 120 Pt 10 (1997) 1723-1737
30. Andersen P.M., Sims K.B., Xin W.W., Kiely R., O'Neill G., Ravits J., Pioro E., Harati Y., Brower R.D., Levine J.S., Heinicke H.U., Seltzer W., Boss M., and Brown Jr. R.H. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 4 (2003) 62-73
31. Aguirre T., Matthijs G., Robberecht W., Tilkin P., and Cassiman J.J. Mutational analysis of the Cu/Zn superoxide dismutase gene in 23 familial and 69 sporadic cases of amyotrophic lateral sclerosis in Belgium. Eur. J. Hum. Genet. 7 (1999) 599-602
32. Robberecht W., Aguirre T., Van den Bosch L., Tilkin P., Cassiman J.J., and Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 47 (1996) 1336-1339
33. Al-Chalabi A., Andersen P.M., Chioza B., Shaw C., Sham P.C., Robberecht W., Matthijs G., Camu W., Marklund S.L., Forsgren L., Rouleau G., Laing N.G., Hurse P.V., Siddique T., Leigh P.N., and Powell J.F. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum. Mol. Genet. 7 (1998) 2045-2050
34. Cudkowicz M.E., and Brown Jr. R.H. An update on superoxide dismutase 1 in familial amyotrophic lateral sclerosis. J. Neurol. Sci. 139 (1996) 10-15 (Suppl.)
35. Cudkowicz M.E., McKenna-Yasek D., Sapp P.E., Chin W., Geller B., Hayden D.L., Schoenfeld D.A., Hosler B.A., Horvitz H.R., and Brown R.H. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 41 (1997) 210-221
36. Regal L., Vanopdenbosch L., Tilkin P., Van den Bosch L., Thijs V., Sciot R., and Robberecht W. The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis. Arch. Neurol. 63 (2006) 262-267
37. Parton M.J., Broom W., Andersen P.M., Al-Chalabi A., Nigel Leigh P., Powell J.F., and Shaw C.E. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Hum. Mutat. 20 (2002) 473
38. Broom W.J., Russ C., Sapp P.C., McKenna-Yasek D., Hosler B.A., Andersen P.M., and Brown Jr. R.H. Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes. Neurosci. Lett. 392 (2006) 52-57
39. Jonsson P.A., Backstrand A., Andersen P.M., Jacobsson J., Parton M., Shaw C., Swingler R., Shaw P.J., Robberecht W., Ludolph A.C., Siddique T., Skvortsova V.I., and Marklund S.L. CuZn-superoxide dismutase in D90A heterozygotes from recessive and dominant ALS pedigrees. Neurobiol. Dis. 10 (2002) 327-333
40. Hand C.K., Mayeux-Portas V., Khoris J., Briolotti V., Clavelou P., Camu W., and Rouleau G.A. Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family. Ann. Neurol. 49 (2001) 267-271
41. Adler R., Landa K.B., Manthorpe M., and Varon S. Cholinergic neuronotrophic factors: intraocular distribution of trophic activity for ciliary neurons. Science 204 (1979) 1434-1436
42. Lo A.C., Li L., Oppenheim R.W., Prevette D., and Houenou L.J. Ciliary neurotrophic factor promotes the survival of spinal sensory neurons following axotomy but not during the period of programmed cell death. Exp. Neurol. 134 (1995) 49-55
43. Sendtner M., Arakawa Y., Stockli K.A., Kreutzberg G.W., and Thoenen H. Effect of ciliary neurotrophic factor (CNTF) on motoneuron survival. J. Cell Sci., Suppl. 15 (1991) 103-109
44. Sendtner M., Kreutzberg G.W., and Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345 (1990) 440-441
45. Ip N.Y., and Yancopoulos G.D. The neurotrophins and CNTF: two families of collaborative neurotrophic factors. Annu. Rev. Neurosci. 19 (1996) 491-515
46. Sendtner M., Schmalbruch H., Stockli K.A., Carroll P., Kreutzberg G.W., and Thoenen H. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358 (1992) 502-504
47. Masu Y., Wolf E., Holtmann B., Sendtner M., Brem G., and Thoenen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature 365 (1993) 27-32
48. Gelernter J., Van Dyck C., van Kammen D.P., Malison R., Price L.H., Cubells J.F., Berman R., Charney D.S., and Heninger G. Ciliary neurotrophic factor null allele frequencies in schizophrenia, affective disorders, and Alzheimer's disease. Am. J. Med. Genet. 74 (1997) 497-500
49. Orrell R.W., King A.W., Lane R.J., and de Belleroche J.S. Investigation of a null mutation of the CNTF gene in familial amyotrophic lateral sclerosis. J. Neurol. Sci. 132 (1995) 126-128
50. Takahashi R. Deficiency of human ciliary neurotropic factor (CNTF) is not causally related to amyotrophic lateral sclerosis (ALS). Rinsho Shinkeigaku 35 (1995) 1543-1545
51. Takahashi R., Yokoji H., Misawa H., Hayashi M., Hu J., and Deguchi T. A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat. Genet. 7 (1994) 79-84
52. Giess R., Goetz R., Schrank B., Ochs G., Sendtner M., and Toyka K. Potential implications of a ciliary neurotrophic factor gene mutation in a German population of patients with motor neuron disease. Muscle Nerve 21 (1998) 236-238
53. Al-Chalabi A., Scheffler M.D., Smith B.N., Parton M.J., Cudkowicz M.E., Andersen P.M., Hayden D.L., Hansen V.K., Turner M.R., Shaw C.E., Leigh P.N., and Brown Jr. R.H. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis. Ann. Neurol. 54 (2003) 130-134
54. Fong G.H., Rossant J., Gertsenstein M., and Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376 (1995) 66-70
55. Soker S., Takashima S., Miao H.Q., Neufeld G., and Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92 (1998) 735-745
56. Lennmyr F., Ata K.A., Funa K., Olsson Y., and Terent A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J. Neuropathol. Exp. Neurol. 57 (1998) 874-882
57. Yang K., and Cepko C.L. Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J. Neurosci. 16 (1996) 6089-6099
58. Sondell M., Lundborg G., and Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19 (1999) 5731-5740
59. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., and Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28 (2001) 131-138
60. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., van Marion I., Al-Chalabi A., Bornes S., Musson R., Hansen V., Beckman L., Adolfsson R., Pall H.S., Prats H., Vermeire S., Rutgeerts P., Katayama S., Awata T., Leigh N., Lang-Lazdunski L., Dewerchin M., Shaw C., Moons L., Vlietinck R., Morrison K.E., Robberecht W., Van Broeckhoven C., Collen D., Andersen P.M., and Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34 (2003) 383-394
61. Van Vught P.W., Sutedja N.A., Veldink J.H., Koeleman B.P., Groeneveld G.J., Wijmenga C., Uitdehaag B.M., de Jong J.M., Baas F., Wokke J.H., and Van den Berg L.H. Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology 65 (2005) 1643-1645
62. Zhang Y., Zhang H., Fu Y., Song H., Wang L., Zhang J., and Fan D. VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 7 (2006) 119-122
63. Brockington A., Kirby J., Eggitt D., Schofield E., Morris C., Lewis C.E., Ince P.G., and Shaw P.J. Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis. Neurogenetics 6 (2005) 101-104
64. Fernandez-Santiago R., Sharma M., Mueller J.C., Gohlke H., Illig T., Anneser J., Munch C., Ludolph A., Kamm C., and Gasser T. Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS. Neurology 66 (2006) 1929-1931
65. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., Morrison K.E., Green A., Acharya K.R., Brown R.H., and Hardiman O. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat. Genet. (2006)
66. Delisle M.B., and Carpenter S. Neurofibrillary axonal swellings and amyotrophic lateral sclerosis. J. Neurol. Sci. 63 (1984) 241-250
67. Matsumoto S., Kusaka H., Murakami N., Hashizume Y., Okazaki H., and Hirano A. Basophilic inclusions in sporadic juvenile amyotrophic lateral sclerosis: an immunocytochemical and ultrastructural study. Acta Neuropathol. (Berl.) 83 (1992) 579-583
68. Mizusawa H., Matsumoto S., Yen S.H., Hirano A., Rojas-Corona R.R., and Donnenfeld H. Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.) 79 (1989) 37-43
69. Troost D., Sillevis Smitt P.A., de Jong J.M., and Swaab D.F. Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.) 84 (1992) 664-673
70. Cote F., Collard J.F., and Julien J.P. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73 (1993) 35-46
71. Xu Z., Cork L.C., Griffin J.W., and Cleveland D.W. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73 (1993) 23-33
72. Williamson T.L., Bruijn L.I., Zhu Q., Anderson K.L., Anderson S.D., Julien J.P., and Cleveland D.W. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9631-9636
73. Couillard-Despres S., Zhu Q., Wong P.C., Price D.L., Cleveland D.W., and Julien J.P. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9626-9630
74. Kong J., and Xu Z. Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis. Neurosci. Lett. 281 (2000) 72-74
75. Couillard-Despres S., Meier J., and Julien J.P. Extra axonal neurofilaments do not exacerbate disease caused by mutant Cu,Zn superoxide dismutase. Neurobiol. Dis. 7 (2000) 462-470
76. Figlewicz D.A., Rouleau G.A., Krizus A., and Julien J.P. Polymorphism in the multi-phosphorylation domain of the human neurofilament heavy-subunit-encoding gene. Gene 132 (1993) 297-300
77. Figlewicz D.A., Krizus A., Martinoli M.G., Meininger V., Dib M., Rouleau G.A., and Julien J.P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 3 (1994) 1757-1761
78. Rooke K., Figlewicz D.A., Han F.Y., and Rouleau G.A. Analysis of the KSP repeat of the neurofilament heavy subunit in familiar amyotrophic lateral sclerosis. Neurology 46 (1996) 789-790
79. Vechio J.D., Bruijn L.I., Xu Z., Brown Jr. R.H., and Cleveland D.W. Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis. Ann. Neurol. 40 (1996) 603-610
80. Al-Chalabi A., Andersen P.M., Nilsson P., Chioza B., Andersson J.L., Russ C., Shaw C.E., Powell J.F., and Leigh P.N. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet. 8 (1999) 157-164
81. Tomkins J., Usher P., Slade J.Y., Ince P.G., Curtis A., Bushby K., and Shaw P.J. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). NeuroReport 9 (1998) 3967-3970
82. Garcia M.L., Singleton A.B., Hernandez D., Ward C.M., Evey C., Sapp P.A., Hardy J., Brown Jr. R.H., and Cleveland D.W. Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis. Neurobiol. Dis. 21 (2006) 102-109
83. Georgiou D.M., Zidar J., Korosec M., Middleton L.T., Kyriakides T., and Christodoulou K. A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 4 (2002) 93-96
84. Mersiyanova I.V., Perepelov A.V., Polyakov A.V., Sitnikov V.F., Dadali E.L., Oparin R.B., Petrin A.N., and Evgrafov O.V. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 67 (2000) 37-46
85. Portier M.M., de Nechaud B., and Gros F. Peripherin, a new member of the intermediate filament protein family. Dev. Neurosci. 6 (1983) 335-344
86. Gros-Louis F., Lariviere R., Gowing G., Laurent S., Camu W., Bouchard J.P., Meininger V., Rouleau G.A., and Julien J.P. A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J. Biol. Chem. 279 (2004) 45951-45956
87. Leung C.L., He C.Z., Kaufmann P., Chin S.S., Naini A., Liem R.K., Mitsumoto H., and Hays A.P. A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol. 14 (2004) 290-296
88. Murakami T., Nagano I., Hayashi T., Manabe Y., Shoji M., Setoguchi Y., and Abe K. Impaired retrograde axonal transport of adenovirus-mediated E. coli LacZ gene in the mice carrying mutant SOD1 gene. Neurosci. Lett. 308 (2001) 149-152
89. Harada A., Takei Y., Kanai Y., Tanaka Y., Nonaka S., and Hirokawa N. Golgi vesiculation and lysosome dispersion in cells lacking cytoplasmic dynein. J. Cell Biol. 141 (1998) 51-59
90. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., Morgan P.J., Oozageer R., Priestley J.V., Averill S., King V.R., Ball S., Peters J., Toda T., Yamamoto A., Hiraoka Y., Augustin M., Korthaus D., Wattler S., Wabnitz P., Dickneite C., Lampel S., Boehme F., Peraus G., Popp A., Rudelius M., Schlegel J., Fuchs H., Hrabe de Angelis M., Schiavo G., Shima D.T., Russ A.P., Stumm G., Martin J.E., and Fisher E.M. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 (2003) 808-812
91. Ahmad-Annuar A., Shah P., Hafezparast M., Hummerich H., Witherden A.S., Morrison K.E., Shaw P.J., Kirby J., Warner T.T., Crosby A., Proukakis C., Wilkinson P., Orrell R.W., Bradley L., Martin J.E., and Fisher E.M. No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 4 (2003) 150-157
92. Ligon L.A., LaMonte B.H., Wallace K.E., Weber N., Kalb R.G., and Holzbaur E.L. Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons. NeuroReport 16 (2005) 533-536
93. Eaton B.A., Fetter R.D., and Davis G.W. Dynactin is necessary for synapse stabilization. Neuron 34 (2002) 729-741
94. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., Van Winkle T., Howland D.S., and Holzbaur E.L. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34 (2002) 715-727
95. Munch C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A.D., Kurt A., Prudlo J., Peraus G., Hanemann C.O., Stumm G., and Ludolph A.C. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63 (2004) 724-726
96. Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., Brown Jr. R.H., Ludlow C.L., and Fischbeck K.H. Mutant dynactin in motor neuron disease. Nat. Genet. 33 (2003) 455-456
97. Munch C., Rosenbohm A., Sperfeld A.D., Uttner I., Reske S., Krause B.J., Sedlmeier R., Meyer T., Hanemann C.O., Stumm G., and Ludolph A.C. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol. 58 (2005) 777-780
98. Corcia P., Mayeux-Portas V., Khoris J., de Toffol B., Autret A., Muh J.P., Camu W., and Andres C. Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Ann. Neurol. 51 (2002) 243-246
99. Jackson M., Morrison K.E., Al-Chalabi A., Bakker M., and Leigh P.N. Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: homozygous NAIP deletion in a sporadic case. Ann. Neurol. 39 (1996) 796-800
100. Moulard B., Salachas F., Chassande B., Briolotti V., Meininger V., Malafosse A., and Camu W. Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann. Neurol. 43 (1998) 640-644
101. Orrell R.W., Habgood J.J., de Belleroche J.S., and Lane R.J. The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS. J. Neurol. Sci. 145 (1997) 55-61
102. Parboosingh J.S., Meininger V., McKenna-Yasek D., Brown Jr. R.H., and Rouleau G.A. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. Arch. Neurol. 56 (1999) 710-712
103. Gamez J., Barcelo M.J., Munoz X., Carmona F., Cusco I., Baiget M., Cervera C., and Tizzano E.F. Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients. Neurology 59 (2002) 1456-1460
104. Veldink J.H., van den Berg L.H., Cobben J.M., Stulp R.P., De Jong J.M., Vogels O.J., Baas F., Wokke J.H., and Scheffer H. Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS. Neurology 56 (2001) 749-752
105. Veldink J.H., Kalmijn S., Van der Hout A.H., Lemmink H.H., Groeneveld G.J., Lummen C., Scheffer H., Wokke J.H., and Van den Berg L.H. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology 65 (2005) 820-825
106. Kunst C.B., Messer L., Gordon J., Haines J., and Patterson D. Genetic mapping of a mouse modifier gene that can prevent ALS onset. Genomics 70 (2000) 181-189
107. Kamel F., Umbach D.M., Lehman T.A., Park L.P., Munsat T.L., Shefner J.M., Sandler D.P., Hu H., and Taylor J.A. Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ. Health Perspect. 111 (2003) 1335-1339
108. Kamel F., Umbach D.M., Munsat T.L., Shefner J.M., Hu H., and Sandler D.P. Lead exposure and amyotrophic lateral sclerosis. Epidemiology 13 (2002) 311-319
109. Hand C.K., Devon R.S., Gros-Louis F., Rochefort D., Khoris J., Meininger V., Bouchard J.P., Camu W., Hayden M.R., and Rouleau G.A. Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis. Arch. Neurol. 60 (2003) 1768-1771
110. Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., Miyamoto N., Showguchi-Miyata J., Okada Y., Singaraja R., Figlewicz D.A., Kwiatkowski T., Hosler B.A., Sagie T., Skaug J., Nasir J., Brown Jr. R.H., Scherer S.W., Rouleau G.A., Hayden M.R., and Ikeda J.E. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 29 (2001) 166-173
111. Yang Y., Hentati A., Deng H.X., Dabbagh O., Sasaki T., Hirano M., Hung W.Y., Ouahchi K., Yan J., Azim A.C., Cole N., Gascon G., Yagmour A., Ben-Hamida M., Pericak-Vance M., Hentati F., and Siddique T. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 29 (2001) 160-165
112. Hosler B.A., Sapp P.C., Berger R., O'Neill G., Bejaoui K., Hamida M.B., Hentati F., Chin W., McKenna-Yasek D., Haines J.L., Patterson D., Horvitz H.R., Brown Jr. R.H., and Day C.B. Refined mapping and characterization of the recessive familial amyotrophic lateral sclerosis locus (ALS2) on chromosome 2q33. Neurogenetics 2 (1998) 34-42
113. Hentati A., Bejaoui K., Pericak-Vance M.A., Hentati F., Speer M.C., Hung W.Y., Figlewicz D.A., Haines J., Rimmler J., Ben Hamida C., et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat. Genet. 7 (1994) 425-428
114. Greenway M.J., Alexander M.D., Ennis S., Traynor B.J., Corr B., Frost E., Green A., and Hardiman O. A novel candidate region for ALS on chromosome 14q11.2. Neurology 63 (2004) 1936-1938
115. Hayward C., Colville S., Swingler R.J., and Brock D.J. Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology 52 (1999) 1899-1901
116. Garofalo O., Figlewicz D.A., Leigh P.N., Powell J.F., Meininger V., Dib M., and Rouleau G.A. Androgen receptor gene polymorphisms in amyotrophic lateral sclerosis. Neuromuscul. Disord. 3 (1993) 195-199
117. Silahtaroglu A.N., Brondum-Nielsen K., Gredal O., Werdelin L., Panas M., Petersen M.B., Tommerup N., and Tumer Z. Human CCS gene: genomic organization and exclusion as a candidate for amyotrophic lateral sclerosis (ALS). BMC Genet. 3 (2002) 5
118. DeChiara T.M., Vejsada R., Poueymirou W.T., Acheson A., Suri C., Conover J.C., Friedman B., McClain J., Pan L., Stahl N., et al. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 83 (1995) 313-322
119. Giess R., Holtmann B., Braga M., Grimm T., Muller-Myhsok B., Toyka K.V., and Sendtner M. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene. Am. J. Hum. Genet. 70 (2002) 1277-1286
120. Nicholl D.J., Bennett P., Hiller L., Bonifati V., Vanacore N., Fabbrini G., Marconi R., Colosimo C., Lamberti P., Stocchi F., Bonuccelli U., Vieregge P., Ramsden D.B., Meco G., and Williams A.C. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology 53 (1999) 1415-1421
121. Siddons M.A., Pickering-Brown S.M., Mann D.M., Owen F., and Cooper P.N. Debrisoquine hydroxylase gene polymorphism frequencies in patients with amyotrophic lateral sclerosis. Neurosci. Lett. 208 (1996) 65-68
122. Flowers J.M., Powell J.F., Leigh P.N., Andersen P., and Shaw C.E. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis. Ann. Neurol. 49 (2001) 643-649
123. Honig L.S., Chambliss D.D., Bigio E.H., Carroll S.L., and Elliott J.L. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology 55 (2000) 1082-1088
124. Jackson M., Steers G., Leigh P.N., and Morrison K.E. Polymorphisms in the glutamate transporter gene EAAT2 in European ALS patients. J. Neurol. 246 (1999) 1140-1144
125. Meyer T., Fromm A., Munch C., Schwalenstocker B., Fray A.E., Ince P.G., Stamm S., Gron G., Ludolph A.C., and Shaw P.J. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J. Neurol. Sci. 170 (1999) 45-50
126. Meyer T., Munch C., Volkel H., Booms P., and Ludolph A.C. The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia. J. Neurol., Neurosurg. Psychiatry 65 (1998) 594-596
127. Aoki M., Lin C.L., Rothstein J.D., Geller B.A., Hosler B.A., Munsat T.L., Horvitz H.R., and Brown Jr. R.H. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann. Neurol. 43 (1998) 645-653
128. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., and Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20 (1998) 589-602
129. Drory V.E., Birnbaum M., Peleg L., Goldman B., and Korczyn A.D. Hexosaminidase A deficiency is an uncommon cause of a syndrome mimicking amyotrophic lateral sclerosis. Muscle Nerve 28 (2003) 109-112
130. Wang X.S., Lee S., Simmons Z., Boyer P., Scott K., Liu W., and Connor J. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences. J. Neurol. Sci. 227 (2004) 27-33
131. Yen A.A., Simpson E.P., Henkel J.S., Beers D.R., and Appel S.H. HFE mutations are not strongly associated with sporadic ALS. Neurology 62 (2004) 1611-1612
132. Giess R., Beck M., Goetz R., Nitsch R.M., Toyka K.V., and Sendtner M. Potential role of LIF as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis. Neurology 54 (2000) 1003-1005
133. Meyer M.A., and Potter N.T. Sporadic ALS and chromosome 22: evidence for a possible neurofilament gene defect. Muscle Nerve 18 (1995) 536-539
134. Chioza B.A., Ujfalusy A., Csiszar K., Leigh P.N., Powell J.F., and Radunovic A. Mutations in the lysyl oxidase gene are not associated with amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 2 (2001) 93-97
135. Orru S., Mascia V., Casula M., Giuressi E., Loizedda A., Carcassi C., Giagheddu M., and Contu L. Association of monoamine oxidase B alleles with age at onset in amyotrophic lateral sclerosis. Neuromuscul. Disord. 9 (1999) 593-597
136. Kowalska A., Konagaya M., Sakai M., Hashizume Y., and Tabira T. Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex-tauopathy without mutations in the tau gene?. Folia Neuropathol. 41 (2003) 59-64
137. Poorkaj P., Tsuang D., Wijsman E., Steinbart E., Garruto R.M., Craig U.K., Chapman N.H., Anderson L., Bird T.D., Plato C.C., Perl D.P., Weiderholt W., Galasko D., and Schellenberg G.D. TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam. Arch. Neurol. 58 (2001) 1871-1878
138. Dhaliwal G.K., and Grewal R.P. Mitochondrial DNA deletion mutation levels are elevated in ALS brains. NeuroReport 11 (2000) 2507-2509
139. Gajewski C.D., Lin M.T., Cudkowicz M.E., Beal M.F., and Manfredi G. Mitochondrial DNA from platelets of sporadic ALS patients restores
140. Mawrin C., Kirches E., and Dietzmann K. Single-cell analysis of mtDNA in amyotrophic lateral sclerosis: towards the characterization of individual neurons in neurodegenerative disorders. Pathol. Res. Pract. 199 (2003) 415-418
141. Mawrin C., Kirches E., Krause G., Wiedemann F.R., Vorwerk C.K., Bogerts B., Schildhaus H.U., Dietzmann K., and Schneider-Stock R. Single-cell analysis of mtDNA deletion levels in sporadic amyotrophic lateral sclerosis. NeuroReport 15 (2004) 939-943
142. Ro L.S., Lai S.L., Chen C.M., and Chen S.T. Deleted 4977-bp mitochondrial DNA mutation is associated with sporadic amyotrophic lateral sclerosis: a hospital-based case-control study. Muscle Nerve 28 (2003) 737-743
143. Swerdlow R.H., Parks J.K., Cassarino D.S., Trimmer P.A., Miller S.W., Maguire D.J., Sheehan J.P., Maguire R.S., Pattee G., Juel V.C., Phillips L.H., Tuttle J.B., Bennett Jr. J.P., Davis R.E., and Parker Jr. W.D. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp. Neurol. 153 (1998) 135-142
144. Wiedemann F.R., Manfredi G., Mawrin C., Beal M.F., and Schon E.A. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 80 (2002) 616-625
145. Lin F.H., Lin R., Wisniewski H.M., Hwang Y.W., Grundke-Iqbal I., Healy-Louie G., and Iqbal K. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem. Biophys. Res. Commun. 182 (1992) 238-246
146. Julien J.P., Cote F., and Collard J.F. Mice overexpressing the human neurofilament heavy gene as a model of ALS. Neurobiol. Aging 16 (1995) 487-490 (discussion 490-2)
147. Panas M., Karadima G., Kalfakis N., Psarrou O., Floroskoufi P., Kladi A., Petersen M.B., and Vassilopoulos D. Genotyping of presenilin-1 polymorphism in amyotrophic lateral sclerosis. J. Neurol. 247 (2000) 940-942
148. Saunderson R., Yu B., Trent R.J., and Pamphlett R. A polymorphism in the poliovirus receptor gene differs in motor neuron disease. NeuroReport 15 (2004) 383-386
149. Chen Y.Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J., Dierick I., Abel A., Kennerson M.L., Rabin B.A., Nicholson G.A., Auer-Grumbach M., Wagner K., De Jonghe P., Griffin J.W., Fischbeck K.H., Timmerman V., Cornblath D.R., and Chance P.F. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 74 (2004) 1128-1135
150. Corcia P., Khoris J., Couratier P., Mayeux-Portas V., Bieth E., De Toffol B., Autret A., Muh J.P., Andres C., and Camu W. SMN1 gene study in three families in which ALS and spinal muscular atrophy co-exist. Neurology 59 (2002) 1464-1466
151. McDermott C.J., Roberts D., Tomkins J., Bushby K.M., and Shaw P.J. Spastin and paraplegin gene analysis in selected cases of motor neurone disease (MND). Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 4 (2003) 96-99
152. Meyer T., Schwan A., Dullinger J.S., Brocke J., Hoffmann K.T., Nolte C.H., Hopt A., Kopp U., Andersen P., Epplen J.T., and Linke P. Early-onset ALS with long-term survival associated with spastin gene mutation. Neurology 65 (2005) 141-143
153. Flowers J.M., Leigh P.N., Davies A.M., Ninkina N.N., Buchman V.L., Vaughan J., Wood N.W., and Powell J.F. Mutations in the gene encoding human persyn are not associated with amyotrophic lateral sclerosis or familial Parkinson's disease. Neurosci. Lett. 274 (1999) 21-24
154. Tomkins J., Banner S.J., McDermott C.J., and Shaw P.J. Mutation screening of manganese superoxide dismutase in amyotrophic lateral sclerosis. NeuroReport 12 (2001) 2319-2322
155. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., Skehel P., and Zatz M. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75 (2004) 822-831
156. Terry P.D., Kamel F., Umbach D.M., Lehman T.A., Hu H., Sandler D.P., and Taylor J.A. VEGF promoter haplotype and amyotrophic lateral sclerosis (ALS). J. Neurogenet. 18 (2004) 429-434